[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06624189":3,"trial-entities:NCT06624189":72,"trial-summary:NCT06624189":75},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":21,"study_type":22,"primary_purpose":17,"phases":23,"enrollment_info":24,"interventions":27,"primary_outcomes":33,"secondary_outcomes":37,"sex":42,"minimum_age":43,"maximum_age":17,"healthy_volunteers":15,"eligibility_criteria":44,"std_ages":54,"locations":57,"central_contacts":65,"overall_officials":66,"references":70,"see_also_links":71},"NCT06624189","QI-Active Choice CDS","Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis","Active Choice Clinical Decision Support: Hepatocellular Carcinoma Screening in Patients With Cirrhosis","ENROLLING_BY_INVITATION","2026-07-24","2026-02","2026-02-27","2024-11-20","NYU Langone Health","OTHER",false,"The research team will evaluate the effectiveness of an auto-pended bot liver ultrasound order that will prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.",null,[19,20],"Hepatocellular Carcinoma","Cirrhosis",[],"OBSERVATIONAL",[],{"count":25,"type":26},1300,"ESTIMATED",[28],{"type":14,"name":29,"description":30,"armGroupLabels":31},"Auto-pended bot liver ultrasound order","This alert prompt providers at the time of encounter to place appropriate imaging orders for hepatocellular carcinoma (HCC) screening in patients with cirrhosis.",[32],"Intervention: Auto-pended bot liver ultrasound order",[34],{"measure":35,"timeFrame":36},"Percentage of Participants for whom the Physician Completed Ordering of the Pending Liver Ultrasound","Day 1",[38,40],{"measure":39,"timeFrame":36},"Percentage of Participants with Completed Liver Ultrasound Imaging",{"measure":41,"timeFrame":36},"HCC Diagnosis Rate from Completed Liver Ultrasound Imaging","ALL","18 Years",{"inclusion":45,"exclusion":48,"raw_text":53},[46,47],"cirrhosis diagnosis,","6 months or more after since most recent imaging.",[49,50,51,52],"previous liver transplant,","HCC diagnosis,","receiving hospice care,","completed external imaging in the past 6 months.","Inclusion Criteria:\n\n* cirrhosis diagnosis,\n* 6 months or more after since most recent imaging.\n\nExclusion Criteria:\n\n* previous liver transplant,\n* HCC diagnosis,\n* receiving hospice care,\n* completed external imaging in the past 6 months.",[55,56],"ADULT","OLDER_ADULT",[58],{"facility":13,"city":59,"state":59,"zip":60,"country":61,"geoPoint":62},"New York","10016","United States",{"lat":63,"lon":64},40.71427,-74.00597,[],[67],{"name":68,"affiliation":13,"role":69},"Saul Blecker","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":73,"biomarkers":74},[20],[],{"nct_id":4,"found":15,"summary":17,"prompt_version":17}]